Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds – National
The drug tirzepatide, made popular for its treatment of Type 2 diabetes and weight loss, lowers the risk of progression to diabetes by 94 per cent among adults with prediabetes and obesity or who are overweight when taken weekly, according to a new study by the drugmaker Eli Lilly. While the study has not yet…